Direct thrombolytic therapy for thrombosis of a centrifugal flow left ventricular assist device

ASAIO Journal

Volumn 59, Issue 5, 2013, Pages 530-532

  Jabbar, Ali Abdul ^a,b   Yau, Raymond ^b   Frazier, O H ^c   Delgado, Reynolds ^a  

^a TEXAS HEART INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRIFUGAL FLOW; HEART TRANSPLANT; LEFT VENTRICULAR; OPTIMAL APPROACHES; POTENTIALLY FATAL; THIRD GENERATION; THROMBOLYTIC THERAPIES; VENTRICULAR ASSIST DEVICE;

BLOOD; BLOOD VESSELS; CENTRIFUGATION; DISEASES; LEFT VENTRICULAR ASSIST DEVICES; PUMPS;

DRUG THERAPY;

ALTEPLASE; HEMOGLOBIN; LACTATE DEHYDROGENASE; WARFARIN;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CATHETERIZATION; DYSPNEA; FATIGUE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART GRAFT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEFT VENTRICULAR ASSIST DEVICE; MALE; MEDICAL DEVICE COMPLICATION; NONISCHEMIC CARDIOMYOPATHY; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VENTRICULAR ASSIST DEVICE;

CATHETERIZATION; HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; HEMOLYSIS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; QUALITY OF LIFE; THROMBOLYTIC THERAPY; THROMBOSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84883648118     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3182a39628     Document Type: Article

References (11)

1. Kiernan MS, Pham DT, DeNofrio D, Kapur NK: Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. J Thorac Cardiovasc Surg 142: 712-714, 2011.
2. Lietz K, Long JW, Kfoury A.g., et al.: Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: Implications for patient selection. Circulation 116: 497-505, 2007. (Pubitemid 47450258)
3. Miller LW, Pagani FD, Russell S.D., et al.; HeartMate II Clinica nvestigators: use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896, 2007. (Pubitemid 47347322)
4. Rothenburger M, Schmid C, Huelksen g., Loeher A, Scheld HH: Thrombolytic therapy due to thrombus formation associated with left ventricular assist devices. J Heart Lung Transplant 24: 2305, 2005. (Pubitemid 41814763)
5. Vrtovec b, Radovancevic R, Delgado R.M., et al.: Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail 11: 1000-1004, 2009.
6. Heilmann C, geisen u, benk C., et al.: Haemolysis in patients with ventricular assist devices: Major differences between systems. Eur J Cardiothorac Surg 36: 580-584, 2009.
7. Slaughter MS, Rogers Jg, Milano C.A., et al.; HeartMate II Investigators: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361: 2241-2251, 2009.
8. Strueber M, O'Driscoll g, Jansz P, Khaghani A., Levy WC, Wieselthaler GM; HeartWare Investigators: Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 57: 1375-1382, 2011.
9. Delgado R 3rd, Frazier OH, Myers TJ, et al.: Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant 24: 231-233, 2005. (Pubitemid 40215604)
10. Thomas MD, Wood C, Lovett M., Dembo L, O'Driscoll G: Successful treatment of rotary pump thrombus with the glyco-protein IIb/IIIa inhibitor tirofiban. J Heart Lung Transplant 27: 925-927, 2008. (Pubitemid 352024419)
11. Rothenburger M, Wilhelm MJ, Hammel D, et al.: Treatment of thrombus formation associated with the MicroMed Debakey VAD using recombinant tissue plasminogen activator. Circulation 106 (12 suppl 1): I189-I192, 2002.